with transient leakage of fluid into and around the optic nerve head3,4 or to deeper optic nerve head vascular compromise and axoplasmic flow disruption. 1 Retinal new vessels are a recognised, if uncommon, clinical finding in patients with diabetic papillopathy, 2 ,4-6 and non-perfusion has been demonstrated in up to 50% of patients using fluorescein angiography? However, associated disc neovascularisation is rare: to our knowledge it has been reported in only three patients, occurring several weeks after the observation of diabetic papillopathy in each case?,7 Our patient was unusual in presenting with signs of diabetic papillopathy and disc new vessels concurrently. In her case, the disc new vessels were clearly visible on slit-lamp biomicroscopy and were highlighted by the fluorescein angiography as shown in Fig. 1 . However, in cases of less florid neovascularisation, distinction from the surface telangiectatic vessels characteristic of diabetic papillopathy may be more difficult and requires careful observation of the disc vessel pattern. New vessels of ischaemic origin tend to be more randomly orientated and elevated above the plane of the retina and disc, whereas the fine telangiectatic vessels of diabetic papillopathy are more radially orientated and lie within the disc and retina. Fluorescein angiography tends not to be helpful because profuse leakage from the disc vessels can occur in both conditions. 3 From a management standpoint, diabetic papillopathy should be a diagnosis of exclusion, following investigation of other causes of swollen discs. This report highlights the importance of careful funduscopy to identify coexisting severe diabetic retinopathy and, in particular, optic disc neovascularisation. Latanoprost is a topical ocular hypotensive medication (prostaglandin F 2 o: analogue) which works via the uveoscleral pathway.l To the best of our knowledge, choroidal detachment caused by latanoprost in a glaucoma patient following cataract surgery has not been described. We report the following case to illustrate a potential side-effect of latanoprost.
Case re p ort He underwent an uneventful right phacoemulsification with posterior implant under local anaesthetic in November 1999. The pre-operative visual acuity was 6/9 in the right eye with an lOP of 16 mmHg. His immediate post-operative period was unremarkable, with a visual acuity of 6/9 and an lOP of 16 mmHg on latanoprost and bethamethasone at 1 week. He presented 6 weeks post-operatively with a painful right eye. Examination revealed a visual acuity of 6/24 in the right eye and an lOP of 0 mmHg. The Seidel test was negative. The anterior chamber was deep and quiet. Fundal examination showed a large choroidal detachment in the supranasal and supratemporal areas. Latanoprost was discontinued and prednisolone 0.5% 4 times a day was started in the right eye. Four weeks later, the visual acuity in the right eye recovered to 6/9 with an lOP of 19 mmHg, and a complete resolution of choroidal effusion. At 3 months follow-up his lOP in the right eye remained controlled at 12 mmHg without treatment.
Comment
Our case illustrates a patient with poorly controlled glaucoma whose lOP stabilised on latanoprost treatment but who later developed profound hypotony following cataract extraction.
The pressure-lowering effect of phacoemulsification has been described in a number of studies, typically in the range of 1.1-2.5 mmHg. 2 In another study, the pressure-lowering effect of phacoemulsification in glaucoma patients was not effective until a year later. 3 The mechanism by which phacoemulsification lowers lOP is unclear, but it is thought to be related to the deepening of the anterior chamber and an improvement in outflow facility.4 Chronic post-operative uveitis may lead to hypotony.5 However, in our patient the reduction in lOP following phacoemulsification was more profound than described in previous studies. In addition, hypotony did not develop until 6 weeks after the operation. There was no significant anterior chamber activity to suggest chronic uveitis. Withdrawal of latanoprost led to complete resolution of choroidal detachment and hypotony. It therefore appears likely that latanoprost had a contributory role in the profound hypotony in this patient, possibly working synergistically with the post-phacoemulsification effect in lowering the lOP.
Latanoprost is known to work by increasing the uveoscleral outflowl and its pressure-lowering effect does not rely on the episcleral pressure of the eye. It can exert its pressure-lowering effect even when the lOP is lower than the episcleral pressure. Our patient was known to respond very well to latanoprost, which reduced the lOP by 14 mmHg (or over 50%) from baseline. The increase in outflow facility following phacoemulsification may have been enhanced by the pharmacological effect of latanoprost,6 resulting in the profound hypotony experienced by our patient in the immediate post operative period. Although Scherer et a/.6 described latanoprost as a safe and effective method for reducing the lOP following cataract extraction, our case suggests that clinicians should be aware of the potential complication in glaucoma patients, particularly if there has been a previous history of good response to latanoprost.
